Table 2.
essential hypertensive groups | |||
---|---|---|---|
|
nonmicroalbuminuric |
microalbuminuric |
healthy controls |
|
(n = 50) |
(n = 43) |
(n = 80) |
IMT(mm) |
0.87 ± 0.14* |
1.08 ± 0.16*# |
0.65 ± 0.14 |
PSV(cm/s) |
96.25 ± 26.96 |
95.97 ± 25.28 |
95.34 ± 25.58 |
EDV(cm/s) |
15.17 ± 5.12 |
15.46 ± 5.89 |
17.13 ± 6.32 |
stiffness |
455.75 ± 199.38* |
614.59 ± 234.38*# |
382.14 ± 165.23 |
tensity |
14.93 ± 7.42 |
12.01 ± 6.05*# |
15.38 ± 7.58 |
distensibility |
0.69 ± 0.21 |
0.46 ± 0.17*# |
0.96 ± 0.31 |
cf-PWV(ms) |
10.40 ±1.98* |
12.26 ± 2.13*# |
8.67 ± 2.90 |
YKL-40(ng/ml) | 61.63 ± 18.58* | 98.78 ± 19.83*# | 37.85 ± 14.12 |
Data are presented as mean ± SD. IMT: intima-media thickness; PSV: peak systolic velocity; EDV: end diastolic velocity; PWV: pulse wave velocity; *P<0.05 vs healthy controls; #P<0.05 vs nonmicroalbuminuric.